Regulation of osteoclast function and bone mass by RAGE

Journal of Experimental Medicine

Volumn 203, Issue 4, 2006, Pages 1067-1080

  Zhou, Zheng ^a   Immel, David ^b   Xi, Cai Xia ^a   Bierhaus, Angelika ^c   Feng, Xu ^d   Mei, Lin ^a   Nawroth, Peter ^c   Stern, David M ^e   Xiong, Wen Cheng ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b SAVANNAH RIVER NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADVANCED GLYCATION END PRODUCT; BETA3 INTEGRIN; CD51 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE REMODELING; CELL ADHESION; CELL FUNCTION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOSCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ACTINS; ANIMALS; BONE AND BONES; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOSKELETON; DOWN-REGULATION; INTEGRIN ALPHAVBETA3; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS;

EID: 33645880137     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051947     Document Type: Article

References (61)

1. Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature. 423:337-342.
2. Tanaka, S., N. Takahashi, N. Udagawa, T. Tamura, T. Akatsu, E.R. Stanley, T. Kurokawa, and T. Suda. 1993. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91:257-263.
3. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:3597-3602.
4. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176.
5. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 428:758-763.
6. Cella, M., C. Buonsanti, C. Strader, T. Kondo, A. Salmaggi, and M. Colonna. 2003. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198:645-651.
7. Paloneva, J., J. Mandelin, A. Kiialainen, T. Bohling, J. Prudlo, P. Hakola, M. Haltia, Y.T. Konttinen, and L. Peltonen. 2003. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J. Exp. Med. 198:669-675.
8. Colonna, M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3:445-453.
9. Yagi, M., T. Miyamoto, Y. Sawatani, K. Iwamoto, N. Hosogane, N. Fujita, K. Morita, K. Ninomiya, T. Suzuki, K. Miyamoto, et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202:345-351.
10. Kim, N., Y. Kadono, M. Takami, J. Lee, S.H. Lee, F. Okada, J.H. Kim, T. Kobayashi, P.R. Odgren, H. Nakano, et al. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202:589-595.
11. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195:201-209.
12. Teitelbaum, S.L. 2000. Osteoclasts, integrins, and osteoporosis. J. Bone Miner. Metab. 18:344-349.
13. Wang, Q., Y. Xie, Q.S. Du, X.J. Wu, X. Feng, L. Mei, J.M. McDonald, and W.C. Xiong. 2003. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J. Cell Biol. 160:565-575.
14. Chellaiah, M., N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski, and K.A. Hruska. 2000. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J. Cell Biol. 148:665-678.
15. Marchisio, P.C., D. Cirillo, L. Naldini, M.V. Primavera, A. Teti, and A. Zambonin-Zallone. 1984. Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J. Cell Biol. 99:1696-1705.
16. Boyce, B.F., T. Yoneda, C. Lowe, P. Soriano, and G.R. Mundy. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1622-1627.
17. Pfaff, M., and P. Jurdic. 2001. Podosomes in osteoclast-like cells: structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin alphaVbeta 3. J. Cell Sci. 114: 2775-2786.
18. Duong, L.T., P.T. Lakkakorpi, I. Nakamura, M. Machwate, R.M. Nagy, and G.A. Rodan. 1998. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J. Clin. Invest. 102:881-892.
19. Nakamura, I., E. Jimi, L.T. Duong, T. Sasaki, N. Takahashi, G.A. Rodan, and T. Suda. 1998. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts. J. Biol. Chem. 273:11144-11149.
20. Sanjay, A., A. Houghton, L. Neff, E. DiDomenico, C. Bardelay, E. Antoine, J. Levy, J. Gailit, D. Bowtell, W.C. Horne, and R. Baron. 2001. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152:181-195.
21. Chiusaroli, R., A. Sanjay, K. Henriksen, M.T. Engsig, W.C. Horne, H. Gu, and R. Baron. 2003. Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossifi cation of cartilage during the development of long bones. Dev. Biol. 261:537-547.
22. Nakamura, I., T. Sasaki, S. Tanaka, N. Takahashi, E. Jimi, T. Kurokawa, Y. Kita, S. Ihara, T. Suda, and Y. Fukui. 1997. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts. J. Cell. Physiol. 172:230-239.
23. Chellaiah, M.A., N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S.F. Dowdy, and K.A. Hruska. 2000. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275:11993-12002.
24. Brownlee, M. 2000. Negative consequences of glycation. Metabolism. 49:9-13.
25. Nawroth, P., A. Bierhaus, M. Marrero, H. Yamamoto, and D.M. Stern. 2005. Atherosclerosis and restenosis: is there a role for RAGE? Curr. Diab. Rep. 5:11-16.
26. Lue, L.F., S.D. Yan, D.M. Stern, and D.G. Walker. 2005. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 4:249-266.
27. Bierhaus, A., P.M. Humpert, D.M. Stern, B. Arnold, and P.P. Nawroth. 2005. Advanced glycation end product receptor-mediated cellular dysfunction. Ann. N. Y. Acad. Sci. 1043:676-680.
28. Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P.M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 50:2792-2808.
29. Chavakis, T., A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K.T. Preissner, and P.P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counter-receptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198:1507-1515.
30. Taguchi, A., D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, et al. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 405:354-360.
31. Lotze, M.T., and K.J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-342.
32. Chavakis, T., A. Bierhaus, and P.P. Nawroth. 2004. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 6:1219-1225.
33. Basta, G., G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, C. Fu, T. Kislinger, D.M. Stern, A.M. Schmidt, and R. De Caterina. 2002. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. 105:816-822.
34. Boulanger, E., M.P. Wautier, J.L. Wautier, B. Boval, Y. Panis, N. Wernert, P.M. Danze, and P. Dequiedt. 2002. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 61:148-156.
35. Treutiger, C.J., G.E. Mullins, A.S. Johansson, A. Rouhiainen, H.M. Rauvala, H. Erlandsson-Harris, U. Andersson, H. Yang, K.J. Tracey, J. Andersson, and J.E. Palmblad. 2003. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254:375-385.
36. Liliensiek, B., M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H.J. Grone, F.C. Kurschus, A.M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113:1641-1650.
37. Constien, R., A. Forde, B. Liliensiek, H.J. Grone, P. Nawroth, G. Hammerling, and B. Arnold. 2001. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis. 30:36-44.
38. Faccio, R., S.L. Teitelbaum, K. Fujikawa, J. Chappel, A. Zallone, V.L. Tybulewicz, F.P. Ross, and W. Swat. 2005. Vav3 regulates osteoclast function and bone mass. Nat. Med. 11:284-290.
39. Takayanagi, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83:170-179.
40. Matsuo, K., and N. Irie. 2005. Transcription factors in osteoclast differentiation. Nippon Rinsho. 63:1541-1546.
41. Woods, D., H. Cherwinski, E. Venetsanakos, A. Bhat, S. Gysin, M. Humbert, P.F. Bray, V.L. Saylor, and M. McMahon. 2001. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol. 21:3192-3205.
42. Faccio, R., S. Takeshita, A. Zallone, F.P. Ross, and S.L. Teitelbaum. 2003. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J. Clin. Invest. 111:749-758.
43. -/- osteoclast phenotype. J. Cell. Biochem. 90:871-883.
44. Xiong, W.C., and X. Feng. 2003. PYK2 and FAK in osteoclasts. Front. Biosci. 8:d1219-d1226.
45. Teitelbaum, S.L., and F.P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-649.
46. McHugh, K.P., K. Hodivala-Dilke, M.H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F.P. Ross, R.O. Hynes, and S.L. Teitelbaum. 2000. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105:433-440.
47. Berry, V., H. Rathod, L.B. Pulman, and H.K. Datta. 1994. Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and avian osteoclasts and its down regulation by calcitonin. J. Endocrinol. 141:R11-R15.
48. Sekimoto, H., J. Eipper-Mains, S. Pond-Tor, and C.M. Boney. 2005. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells. Mol. Endocrinol. 19:1859-1867.
49. Ishihara, K., K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka. 2003. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett. 550:107-113.
50. McDonald, D.R., M.E. Bamberger, C.K. Combs, and G.E. Landreth. 1998. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:4451-4460.
51. Bucciarelli, L.G., T. Wendt, L. Rong, E. Lalla, M.A. Hofmann, M.T. Goova, A. Taguchi, S.F. Yan, S.D. Yan, D.M. Stern, and A.M. Schmidt. 2002. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell. Mol. Life Sci. 59:1117-1128.
52. Wautier, M.P., O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt, and J.L. Wautier. 2001. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280:E685-E694.
53. Basta, G., G. Lazzerini, S. Del Turco, G.M. Ratto, A.M. Schmidt, and R. De Caterina. 2005. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler. Thromb. Vasc. Biol. 25:1401-1407.
54. Mukherjee, T.K., S. Mukhopadhyay, and J.R. Hoidal. 2005. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim. Biophys. Acta. 1744:213-223.
55. Lee, N.K., Y.G. Choi, J.Y. Baik, S.Y. Han, D.W. Jeong, Y.S. Bae, N. Kim, and S.Y. Lee. 2005. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 106:852-859.
56. Ha, H., H.B. Kwak, S.W. Lee, H.M. Jin, H.M. Kim, H.H. Kim, and Z.H. Lee. 2004. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell Res. 301:119-127.
57. Lean, J.M., J.T. Davies, K. Fuller, C.J. Jagger, B. Kirstein, G.A. Partington, Z.L. Urry, and T.J. Chambers. 2003. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J. Clin. Invest. 112:915-923.
58. Dumitriu, I.E., P. Baruah, M.E. Bianchi, A.A. Manfredi, and P. Rovere-Querini. 2005. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35:2184-2190.
59. Dumitriu, I.E., P. Baruah, B. Valentinis, R.E. Voll, M. Herrmann, P.P. Nawroth, B. Arnold, M.E. Bianchi, A.A. Manfredi, and P. Rovere-Querini. 2005. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506-7515.
60. Lam, J., S. Takeshita, J.E. Barker, O. Kanagawa, F.P. Ross, and S.L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488.
61. Ren, X.R., Q.S. Du, Y.Z. Huang, S.Z. Ao, L. Mei, and W.C. Xiong. 2001. Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein. J. Cell Biol. 152:971-984.